Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis

• Published in: Infectious diseases of poverty 2022-11, Vol.11 (1), p.1-113, Article 113
• Main Authors: Holland, Celia, Sepidarkish, Mahdi, Deslyper, Gwendoline, Abdollahi, Ali, Valizadeh, Soghra, Mollalo, Abolfazl, Mahjour, Sanaz, Ghodsian, Sahar, Ardekani, Ali, Behniafar, Hamed, Gasser, Robin B, Rostami, Ali
• Format: Article
• Language: English
• Subjects: Analysis; Ascaris; Bias; Epidemiology; Global prevalence; Health aspects; Heterogeneity; Human populations; Infection; Infections; Intensity of infection; Investigations; Medical research; Medicine, Experimental; Meta-analysis; Population; Prevalence studies (Epidemiology); Relative humidity; Rural areas; Sanitation; Scoping Review; Socioeconomic factors; Socioeconomics; Software; Sustainable development; Systematic review; Tropical diseases
• ISSN: 2049-9957; 2095-5162; 2049-9957
• DOI: 10.1186/s40249-022-01038-z

Background Ascariasis is one of the most important neglected tropical diseases of humans worldwide. The epidemiology of Ascaris infection appears to have changed with improvements in sanitation and mass drug administration, but there is no recent information on prevalence worldwide. Here, we performed a systematic review and meta-analysis to assess the global prevalence of human Ascaris infection from 2010 to 2021. Methods We searched MEDLINE/PubMed, and Scopus databases for studies measuring prevalence of Ascaris infection, published between 1 January 2010 and 1 January 2022. We included studies of the general human population in endemic regions, which used accepted coprodiagnostic methods, and excluded studies of people with occupations with an increased risk or probability of ascariasis and/or specific diseases other than ascariasis. We applied random-effects models to obtain pooled prevalence estimates for six sustainable development goal regions of the world. We extrapolated the prevalence estimates to the global population in 2020, to estimate the number of individuals with Ascaris infection. We conducted multiple subgroup and meta-regression analyses to explore possible sources of heterogeneity, and to assess relationships between prevalence estimates and demographic, socio-economic, geo-climatic factors. Results Of 11,245 studies screened, we analysed 758 prevalence estimates for a total number of 4,923,876 participants in 616 studies from 81 countries. The global prevalence estimated was 11.01% (95% confidence interval: 10.27-11.78%), with regional prevalences ranging from 28.77% (7.07-57.66%) in Melanesia (Oceania) to 1.39% (1.07-1.74%) in Eastern Asia. We estimated that ~ 732 (682-782) million people harboured Ascaris worldwide in 2021. The infected people in Latin America and the Caribbean region had a higher prevalence of high intensity infection (8.4%, 3.9-14.1%). Prevalence estimates were higher in children, and people in rural communities or in countries or regions with lower income and human development indices. There was a trend for a higher prevalence in regions with increasing mean annual relative humidity, precipitation and environmental temperature. Conclusions Our findings indicate that, despite a renewed commitment by some communities or authorities to control ascariasis, a substantial portion of the world's human population (> 0.7 billion) is infected with Ascaris. Despite the clinical and socioeconomic importance of ascariasis, ma